Binfield, United Kingdom

Myrtle Gordon


 

Average Co-Inventor Count = 1.3

ph-index = 1


Location History:

  • London, GB (2014)
  • Binfield, GB (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Myrtle Gordon: Innovator in Cell Culture and Therapeutics

Introduction

Myrtle Gordon is a notable inventor based in Binfield, GB, recognized for her contributions to the field of cell culture and therapeutic applications. With a total of 2 patents, her work focuses on innovative methods that enhance the potential of stem cells and their derivatives.

Latest Patents

Myrtle's latest patents include a culture method that provides techniques for culturing cells while maintaining their differentiation potential. This invention involves contacting cells with an inhibitor of miRNA-181a* and incubating them in a serum-free medium. Additionally, she has developed a serum-free medium that is also part of her patent. Another significant patent is for a medium derived from stem cells, which is described as an apoptosis-modulating cell-free composition. This composition comprises conditioned extracellular medium of a stem cell and has various therapeutic uses. Furthermore, she has outlined a method for obtaining such a composition and an in vitro method for modulating apoptosis.

Career Highlights

Throughout her career, Myrtle has worked with several companies, including Omnicyte Limited and Revealcyte. Her innovative approaches have significantly impacted the field of cell biology and therapeutic development.

Collaborations

Myrtle has collaborated with notable individuals in her field, including Nagy Habib and Nagy A Habib. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Myrtle Gordon's contributions to cell culture and therapeutic innovations highlight her role as a leading inventor in her field. Her patents reflect a commitment to advancing scientific knowledge and improving therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…